Oct 13, 2022 4:30 pm EDT Profound Medical to Release Third Quarter 2022 Financial Results on November 3 – Conference Call to Follow
Sep 26, 2022 8:00 am EDT Four Year Follow-Up Data from Profound Medical’s TACT Pivotal Clinical Trial Confirm Durable and Stable Positive Trends Following Treatment with TULSA-PRO® of Men with Localized Prostate Cancer
Sep 15, 2022 8:00 am EDT Profound Medical Announces Changes to its Commercial Organization to Support Continued Growth
Jul 14, 2022 4:30 pm EDT Profound Medical to Release Second Quarter 2022 Financial Results on August 4 – Conference Call to Follow
Jun 16, 2022 4:30 pm EDT Profound Medical to Participate in the Cowen 7th Annual FutureHealth Conference
Jun 2, 2022 4:30 pm EDT Profound Medical to Participate in the 2022 Jefferies Global Healthcare Conference